Biogen, Inc. (BIIB)
200.03
+5.79
(+2.98%)
USD |
NASDAQ |
Jun 11, 14:52
Biogen Accounts Payable (Quarterly) : 358.50M for March 31, 2026
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Accounts Payable (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 358.50M |
| December 31, 2025 | 432.00M |
| September 30, 2025 | 413.10M |
| June 30, 2025 | 408.40M |
| March 31, 2025 | 391.50M |
| December 31, 2024 | 424.20M |
| September 30, 2024 | 422.70M |
| June 30, 2024 | 354.50M |
| March 31, 2024 | 387.00M |
| December 31, 2023 | 403.30M |
| September 30, 2023 | 440.10M |
| June 30, 2023 | 445.40M |
| March 31, 2023 | 491.20M |
| December 31, 2022 | 491.50M |
| September 30, 2022 | 383.20M |
| June 30, 2022 | 434.80M |
| March 31, 2022 | 398.70M |
| December 31, 2021 | 589.20M |
| September 30, 2021 | 427.90M |
| June 30, 2021 | 375.30M |
| March 31, 2021 | 430.40M |
| December 31, 2020 | 454.90M |
| September 30, 2020 | 398.40M |
| June 30, 2020 | 383.90M |
| March 31, 2020 | 389.00M |
| Date | Value |
|---|---|
| December 31, 2019 | 530.80M |
| September 30, 2019 | 382.20M |
| June 30, 2019 | 377.10M |
| March 31, 2019 | 378.00M |
| December 31, 2018 | 370.50M |
| September 30, 2018 | 342.30M |
| June 30, 2018 | 295.70M |
| March 31, 2018 | 345.80M |
| December 31, 2017 | 395.50M |
| September 30, 2017 | 298.70M |
| June 30, 2017 | 330.30M |
| March 31, 2017 | 316.40M |
| December 31, 2016 | 279.80M |
| September 30, 2016 | 274.00M |
| June 30, 2016 | 225.90M |
| March 31, 2016 | 271.30M |
| December 31, 2015 | 267.40M |
| September 30, 2015 | 251.23M |
| June 30, 2015 | 282.70M |
| March 31, 2015 | 236.13M |
| December 31, 2014 | 229.18M |
| September 30, 2014 | 233.63M |
| June 30, 2014 | 224.93M |
| March 31, 2014 | 212.81M |
| December 31, 2013 | 219.91M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 645.00M |
| AbbVie, Inc. | 33.61B |
| Amgen, Inc. | 2.935B |
| Regeneron Pharmaceuticals, Inc. | 1.027B |
| Ionis Pharmaceuticals, Inc. | 26.03M |